Hoth Therapeutics Inc. Stock News

Hoth Therapeutics (HOTH) rises on encouraging pre-clinical data demonstrating cognitive benefits of its novel therapeutic candidate, HT-ALZ, in the treatment of Alzheimer's disease.

NEW YORK , Feb. 13, 2024 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today announced that Robb Knie, Chief Executive Officer, is scheduled to attend the BIO

Hoth Therapeutics (NASDAQ: HOTH ) stock is rocketing higher on Tuesday thanks to the company announcing positive results from a preclinical trial. According to a Hoth Therapeutics press release, these

Are penny stocks worth investing in? The post Are Penny Stocks Worth the Risk?

Hoth Therapeutics Inc HOTH shares are trading lower by 21.22% to $8.44 Friday morning after the company announced a $10 million private placement priced at-the-market under Nasdaq rules.

Hoth Therapeutics (NASDAQ: HOTH ) stock is rising higher on Monday positive results from a Phase 1 clinical trial of BioLexa. BioLexa is a treatment in development at Hoth Therapeutics for mild-to-mod

NEW YORK , Aug. 12, 2022 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused  biopharmaceutical company,  today announced today announced the company will be presenting at the

Hoth Therapeutics Inc (NASDAQ: HOTH) has announced proof-of-concept data generated using cognitive and behavioral assessments in an Alzheimer's disease mouse model. HT-ALZ is therapeutic in develop

Hoth Therapeutics Inc (NASDAQ: HOTH) shares are trading higher by 17% to $0.47 Tuesday morning after the company announced its HT-ALZ therapeutic showed cognitive improvements in an Alzheimer's Dis

Check out these tips for buying penny stocks in July 2022 The post What to Know About Buying Penny Stocks in July 2022 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.

Hoth Therapeutics Inc (NASDAQ: HOTH) has added a new asset, HT-TBI, as a novel, point-of-care therapy to treat secondary brain injury resulting from ischemic stroke and traumatic brain injury (TBI).

Dr. Yuede will present the preclinical Alzheimer's disease mouse model data for exploring HT-ALZ for the treatment of Alzheimer's disease NEW YORK , April 12, 2022 /PRNewswire/ -- Hoth Therapeutics, I

Trading volume is a simple way to measure how much of a security is being traded over a period of time. A high trading volume indicates high buying pressure if the stock is moving higher, or high sell

Hoth Therapeutics (HOTH) stock is rising higher on Monday after the biopharmaceutical company provided an update on HT-KIT. The post Why Is Hoth Therapeutics (HOTH) Stock Skyrocketing 110% Today?

Hoth Therapeutics Inc (NASDAQ: HOTH) shares are surging after announcing development updates for its novel cancer therapeutic, HT-KIT. Through a sponsored scientific research agreement with North C